510(k) · Cleared
ClearedSanarus Centrica II Rotational Core Biopsy System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Sanarus Medical, Inc. · KNW Instrument, Biopsy
Cleared on Oct 9, 2003 as substantially equivalent to K022879 (Sanarus Medical, Inc., 2002) after a 56-day review. Its family tree reaches back 3 generations to 2001. 9 later devices descend from it.
- Decided
- Oct 9, 2003
- Review
- 56 days
- Class
- Class II
- Product code
- KNW
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K003528 (2001). 9 later devices descend from it, 1 citing it directly.
- Root · 3 generations backK003528 Sanarus Core Tissue Biopsy SystemEndocare, Inc. · 2001
- 2 generations backK021137 Sanarus Centrica Core Tissue Biopsy SystemSanarus Medical, Inc. · 2002
- 1 generation backK022879 Modification to Sanarus Centrica Core Tissue BiopsySanarus Medical, Inc. · 2002 · Recalled
- This deviceK032506 Sanarus Centrica II Rotational Core Biopsy SystemSanarus Medical, Inc. · 2003
- Descendant · cites it directly · 8 of its ownK042136 Sanarus Cassi Rotational Core Biopsy SystemSanarus Medical, Inc. · 2004
- Descendant · 2 generations on · 4 of its ownK051581 Sanarus Cassi II Rotational Core Biopsy System, Model CS2000Sanarus Medical, Inc. · 2005
- Descendant · 2 generations on · 3 of its ownK053151 Rubicor Magic Breast Biopsy DeviceRubicor Medical, Inc. · 2005
- Descendant · 3 generations on · 1 of its ownK123606 Cassi II Rotational Core Biopsy System; Cassi Quadpoint DisposableScion Medical Technologies, LLC · 2013
- Descendant · 3 generations on · 1 of its ownK071048 Rubicor Magic Breast Biopsy Device, Model 31537Rubicor Medical, Inc. · 2007
Showing 5 of 9 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 9 · See all- K042136Sanarus Cassi Rotational Core Biopsy SystemSanarus Medical, Inc. · 2004 · cites it directly8descendants
- K051581Sanarus Cassi II Rotational Core Biopsy System, Model CS2000Sanarus Medical, Inc. · 2005 · 2 generations on4descendants
- K053151Rubicor Magic Breast Biopsy DeviceRubicor Medical, Inc. · 2005 · 2 generations on3descendants
- K123606Cassi II Rotational Core Biopsy System; Cassi Quadpoint DisposableScion Medical Technologies, LLC · 2013 · 3 generations on1descendant
- K071048Rubicor Magic Breast Biopsy Device, Model 31537Rubicor Medical, Inc. · 2007 · 3 generations on1descendant
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K003528 | Sanarus Core Tissue Biopsy System | Endocare, Inc. | 2001 | — |
| −2 | K021137 | Sanarus Centrica Core Tissue Biopsy System | Sanarus Medical, Inc. | 2002 | — |
| −1 | K022879 | Modification to Sanarus Centrica Core Tissue Biopsy | Sanarus Medical, Inc. | 2002 | 1 |
| 0 (this device) | K032506 | Sanarus Centrica II Rotational Core Biopsy System | Sanarus Medical, Inc. | 2003 | — |
| +1 | K042136 | Sanarus Cassi Rotational Core Biopsy System | Sanarus Medical, Inc. | 2004 | — |
| +2 | K051581 | Sanarus Cassi II Rotational Core Biopsy System, Model CS2000 | Sanarus Medical, Inc. | 2005 | — |
| +2 | K053151 | Rubicor Magic Breast Biopsy Device | Rubicor Medical, Inc. | 2005 | — |
| +3 | K123606 | Cassi II Rotational Core Biopsy System; Cassi Quadpoint Disposable | Scion Medical Technologies, LLC | 2013 | — |
| +3 | K071048 | Rubicor Magic Breast Biopsy Device, Model 31537 | Rubicor Medical, Inc. | 2007 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2004 | 1 | 0 |
| 2005 | 2 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2016 | 1 | 0 |
| 2018 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in KNW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new KNW device
- #1 K260572 Marrow Marxmanscore 14.5 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K022879 | Modification to Sanarus Centrica Core Tissue BiopsySummary page 2…ystem is substantially equivalent to the Centrica Rotational Core Biopsy System that was determined to be substantially equivalent on Sep 23, 2002 (reference K022879). The Sanarus Centrica I I Rotational Core Biopsy System has the same indications for use and technological characte… | 2002 |
What descends from it? (9)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K042136 | Sanarus Cassi Rotational Core Biopsy System | 2004 | 8 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 2 years and passes through 2 companies; a new generation was cleared every 1.0 years on median.
- 1 of the 3 ancestors has a recall of any class.
- Of its descendants, K042136 (Sanarus Medical, Inc., 2004) has gone furthest, with 8 descendants of its own.
How does its category compare?
All KNW devicesKNW Instrument, Biopsy: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · KNW
12in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · KNW
178in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · KNW
1in 2024
Class I (4 since 2007) Class II/III not classified
Adverse event reports per year · KNW
1,667in 2025
MAUDE reports naming product code KNW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 6 | 94 | 1 | 766 |
| 2008 | 4 | 53 | 7 | 363 |
| 2009 | 6 | 35 | 3 | 351 |
| 2010 | 3 | 57 | 2 | 162 |
| 2011 | 10 | 64 | 5 | 67 |
| 2012 | 7 | 94 | 1 | 93 |
| 2013 | 3 | 100 | 1 (1) | 98 |
| 2014 | 8 | 95 | 3 | 193 |
| 2015 | 10 | 106 | 0 | 591 |
| 2016 | 9 | 127 | 5 | 297 |
| 2017 | 8 | 90 | 1 | 760 |
| 2018 | 7 | 71 | 0 | 1,012 |
| 2019 | 5 | 94 | 4 | 4,195 |
| 2020 | 8 | 92 | 0 | 5,120 |
| 2021 | 9 | 54 | 3 | 1,020 |
| 2022 | 8 | 203 | 3 | 535 |
| 2023 | 7 | 164 | 2 | 931 |
| 2024 | 5 | 114 | 1 | 1,283 |
| 2025 | 12 | 178 | 0 | 1,667 |
| 2026 | 7 | 29 | 4 (3) | — |
What is it indicated for?
The device is indicated for use in obtaining biopsies from soft tissues such as liver, kidney, prostate, spleen, lymph nodes and various soft tissue tumors. It is not intended for use in bone. The device is also indicated to provide breast tissue samples for diagnostic sampling of breast abnormalities. It is designed to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality. The extent of histologic…
Read the full statement (131 words)
The device is indicated for use in obtaining biopsies from soft tissues such as liver, kidney, prostate, spleen, lymph nodes and various soft tissue tumors. It is not intended for use in bone.
The device is also indicated to provide breast tissue samples for diagnostic sampling of breast abnormalities. It is designed to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality. The extent of histologic abnormality cannot be reliably determined from its mammographic appearance. Therefore, the extent of removal of the imaged evidence of an abnormality does not predict the extent of removal of a histologic abnormality (e.g., malignancy). When the sampled abnormality is not histologically benign, it is essential that the tissue margins be examined for completeness of removal using standard surgical procedures.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K032506 · printed Nov 6, 2026
Cite this page
510(k) Report. “K032506: Sanarus Centrica II Rotational Core Biopsy System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K032506
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026